(Q33886764)

29 July 2017

1 reference

title

Problems in the differential diagnosis of endometrial hyperplasia and carcinoma (English)

1 reference

29 July 2017

endometrial hyperplasia

1 reference

Silverberg SG

1

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

13

1 reference

29 July 2017

3

1 reference

29 July 2017

309-327

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3880053

29 July 2017

0 references

cites work

Theories of endometrial carcinogenesis: a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Endometrial lesions in uteri resected for atypical endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

Endometrial hyperplasia and carcinoma. Are ultrastructural, biochemical and immunocytochemical studies useful in distinguishing between them?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Use of monoclonal antibodies MSN-1 and B72.3 in the prediction of the natural history of endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Advances in endometrial pathology.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Histopathologic analysis of preoperative radiation therapy in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Morphologic and immunophenotypic characterization of foam cells in endometrial lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Foam cells in endometrial carcinoma--a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Genesis of endometrial carcinoma; study of prior biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

What are the earliest endometrial changes to justify a diagnosis of endometrial cancer?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

The precursors of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Molecular biology in the clinicopathologic assessment of endometrial carcinoma subtypes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Secretory adenocarcinoma of the endometrium.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Ciliated carcinoma--a variant of endometrial adenocarcinoma: a report of 10 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Ciliated cell adenocarcinoma of the endometrium diagnosed by endometrial brush cytology and confirmed by hysterectomy: a case report detailing a highly efficient cytology collection and processing technique

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Mixed Adenosquamous Carcinoma of the Endometrium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

An Analysis of Approaches to the Management of Endometrial Cancer in North America: A CTF Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

The prognostic value of semiquantitative nuclear grading in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

An analysis of two versus three grades for endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

The importance of grading in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Intraoperative frozen section examination of myometrial invasion depth in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880053

7 January 2021

10.1038/MODPATHOL.3880053

Identifiers

DOI

1 reference

PubMed ID

10757341

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10757341